Submit your nominations for the EASD Prizes 2025
Who is you favourite candidate to be recognised by a prestigious EASD award for outstanding contributions to diabetes research?
Please refer to the links below for more details on the different prizes and nomination forms. The nomination deadline is 15 February 2025.
Awarded to recognise an individual's innovative leadership and lifetime achievements in diabetes research.
Awarded for excellent research by early career scientists contributing to the advancement of knowledge concerning diabetes.
Awarded to recognise outstanding achievements in the field of pathophysiology and treatment of diabetes.
Awarded to recognise outstanding achievements in research which has led to significant advances in the understanding, prevention or treatment of diabetes or its complications.
Awarded for outstanding contributions in the field of the histopathology, pathogenesis, prevention and treatment of the complications of diabetes.
EFSD welcomes applications for the following diabetes research programmes
EASD Honorary Membership
The voting by EASD members ratified the selection of Polly Bingley, Edwin Gale, Sally Marshall and Gordon Weir to be honoured with EASD lifetime Honorary Membership.
We would like to take this opportunity to thank Polly Bingley, Edwin Gale, Sally Marshall and Gordon Weir for their longstanding membership and congratulate them on their Honorary Membership.
EASD 2024 - Impressions and Highlights
Watch our playlist with highlights, expert interviews and awardee portraits from the 60th EASD Annual Meeting - stay tuned for more videos.
The European Foundation for the Study of Diabetes (EFSD) was created by EASD to provide funding in all areas of diabetes research across the entire European Region. The aims of EFSD are to encourage and support groundbreaking diabetes research and to promote the next generation of leading diabetes researchers.
Diabetologia is the Journal of the EASD and publishes original clinical, translational and experimental research within the field of diabetes. We are interested in papers that convey new information or insight into any aspect of the condition, ranging from basic science to clinical applications.
